Variants in the HEPSIN gene are associated with prostate cancer in men of European origin

Human Genetics

Volumn 120, Issue 2, 2006, Pages 187-192

  Pal, Prodipto ^a   Xi, Huifeng ^a   Kaushal, Ritesh ^a   Sun, Guangyun ^a   Jin, Carol H ^a   Jin, Li ^a   Suarez, Brian K ^b   Catalona, William J ^c   Deka, Ranjan ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; HEPSIN; MEMBRANE PROTEIN; PROTEINASE;

ARTICLE; CANCER GENETICS; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHROMOSOME 11; CHROMOSOME 19Q; CONTROLLED STUDY; EUROPE; GENE FREQUENCY; GENE LOCATION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLEASON SCORE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; SERINE ENDOPEPTIDASES;

EID: 33747016828     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-006-0204-3     Document Type: Article

References (31)

1. Albertsen PC, Hanley JA, Fine J (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293:2095-2101
2. Baker SG, Lichtenstein P, Kaprio J, Holm N (2005) Genetic susceptibility to prostate, breast and colorectal cancer among Nordic twins. Biometrics 61:55-63
3. Boehnke M (1991) Allele frequency estimation from data on relatives. Am J Hum Genet 48:22-25
4. Burmester JK, Suarez BK, Lin JH, Jin CH, Miller RD, Zhang KQ, Salzman SA, Reding DJ, Catalona WJ (2004) Analysis of candidate genes for prostate cancer. Hum Hered 57:172-178
5. Chen Z, Fan Z, McNeal JE, Nolley R, Caldwell MC, Mahadevappa M, Zhang Z, Warrington JA, Stamey TA (2003) Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. J Urol 169:1316-1319
6. Dhanasekaran SM, Barrette TR, Ghosh D, Shah D, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412:822-826
7. Dietmaier W. Hartmann A. Wallinger S. Heinmöller E. Kerner T. Endl E. Jauch K.-W. Hofstädter F. Rüschoff J. (1999) Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Path 154:83-95
8. Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM (2001) Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 68:1197-1206
9. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer Statistics 2006. CA Cancer J Clin 56:106-130
10. Jiang Z, Zhang X, Deka R, Jin L (2005) Genome amplification of single sperm using multiple displacement amplification. Nucleic Acids Res 33:e91
11. Khoury MJ, Beaty TH, Cohen BH (1993) Fundamentals of genetic epidemiology. Oxford University Press, New York
12. Lange K, Weeks D, Boehnke M (1988) Programs for pedigree analysis: MENDEL, FISHER and dGENE. Genet Epidemiol 5:471-472
13. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85
14. Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Catalona WJ, Watson MA, Milbrandt J (2001) Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61:5692-5696
15. Neville PJ, Conti DV, Krumroy LM, Catalona WJ, Suarez BK, Witte JS, Casey G (2003) Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies. Genes Chromosomes Cancer 36:332-339
16. Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM (2002) Meta-analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 62:4427-4433
17. Simard J, Dumont M, Soucy P, Labrie F (2002) Perspective: Prostate cancer susceptibility genes. Endocrinology 143:2029-2040
18. Smith DS, Humphrey PA, Catalona WJ (1997) The early detection of prostate carcinoma with prostate specific antigen: The Washington university experience. Cancer 80:1852-1856
19. Stamey TA, Warrington JA, Caldwell MC, Chen Z, Fan Z, Mahadevappa M, McNeal JE, Nolley R, Zhang Z (2001) Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 166:2171-2177
20. Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristiansen G, Hauptmann S, Kishi T, Nakamura T, Loening SA, Diamandis EP (2004) Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. J Urol 171:187-191
21. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989
22. Suarez BK, Lin J, Burmester JK, Broman KW, Weber JL, Banerjee TK, Goddard KA, Witte JS, Elston RC, Catalona WJ (2000a) A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet 66:933-944
23. Suarez BK, Lin J, Witte JS, Conti DV, Resnick MI, Klein EA, Burmester JK, Vaske DA, Banerjee TK, Catalona WJ (2000b) Replication linkage study for prostate cancer susceptibility genes. Prostate 45:106-114
24. Suarez BK, Pal P, Jin CH, Kaushal R, Sun G, Jin L, Pasche B, Deka R, Catalona WJ (2005) TGFBR1*6A is not associated with prostate cancer in men of European ancestry. Prostate Cancer Prostatic Dis 8:50-53
25. Sun G, Kaushal R, Pal P, Wolujewicz M, Smelser D, Cheng H, Lu M, Chakraborty R, Jin L, Deka R (2005) Whole-genome amplification: Relative efficiencies of the current methods. Legal Med 7:279-286
26. Westfall PH, Young SS (1993) Resampling-based multiple testing: Examples and methods for p -value adjustments. Wiley, New York
27. Witte JS, Goddard KA, Conti DV, Elston RC, Lin J, Suarez BK, Broman KW, Burmester JK, Weber JL, Catalona WJ (2000) Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet 67:92-99
28. Witte JS, Suarez BK, Thiel B, Lin J, Yu A, Banerjee TK, Burmester JK, Caey G, Catalona WJ (2003) Genome-wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate 57:298-308
29. Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumara M, Vedvick TS, Leslie KB, Badaro R, Reed SG (2000) Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 60:1677-1682
30. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh CL, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Kolb S, Badzioch M, Jarvik GP, Janer M, Hood L, Ostrander FA, Stanford JL, Lange FM, Beebe-Dimmer JL, Mohai CE, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLJ, Bailey-Wilson J, Schleufler J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Seminara D (2005) A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 77:219-229
31. Zaykin DV, Westfall PH, Young SS, Karnoub MC, Wagner MJ, Ehm MG (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79-91